Beijing
China
9
2024-05-23
4
2021-08-24
These are the the leading inventors for applications assigned to BEIJING PROTGEN LTD.:
BEIJING PROTGEN LTD. based in Beijing, CN has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
MEDICATION FOR INHIBITING DNA-PKCS
#2 | 2021-03-25MOLECULAR DESIGN OF RECOMBINANT PROTEIN DRUG
#3 | 2020-08-27 ✅ Patent 11,098,104 granted on 2021-08-24Pegylated endostatin analogue and application thereof
#4 | 2018-07-19 ✅ Patent 10,869,910 granted on 2020-12-22Molecular design of recombinant protein drug
#5 | 2018-01-18DRUG FOR INHIBITING ADIPOSE CELL DIFFERENTIATION AND INSULIN RESISTANCE
#6 | 2016-06-23TUMOR BIOMARKER
#7 | 2015-07-16ENDOSTATIN MUTANTS WITH MUTATIONS AT ATP BINDING SITES
#8 | 2014-11-13 ✅ Patent 9,364,493 granted on 2016-06-14Methods and compositions for enhancing the uptake of therapeutic agents by target cells
#9 | 2014-10-16 ✅ Patent 10,647,968 granted on 2020-05-12Endostatin mutants with mutations at ATP binding sites
Also check out BEIJING PROTGEN LTD.'s (Beijing, China) applicant profile with 3 patent applications submitted.
80103 ⎘